Guardant Health

Guardant Health

Yahoo Finance • 9 hours ago

Dow Jones Futures Rise As Micron Jumps On Earnings, Lifting Sandisk, AI Stocks; Fed Inflation Data Due

Micron surged overnight on strong earnings and guidance, lifting other memory and chip plays. The Fed's favorite inflation gauge is on tap. Continue Reading... Full story

Yahoo Finance • 10 hours ago

Dow Jones Futures: Micron Jumps On Earnings, Lifts Memory, Chip Stocks; Fed Inflation Data Due

Micron surged overnight on strong earnings and guidance, lifting other memory and chip plays. The Fed's favorite inflation gauge is on tap. Continue Reading... Full story

Yahoo Finance • yesterday

Dow Jones Futures: Nasdaq Breaks Support Amid AI Sell-Off; FedEx, Cerebras Tumble Late With Micron Due

The Nasdaq broke key support Tuesday as AI stocks sold off, even as SpaceX reversed higher. FedEx and AI chip IPO Cerebras reported late. Micron earnings loom. Continue Reading... Full story

Yahoo Finance • 7 days ago

Living Longer Is Big Business. These Stocks Will Benefit.

TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion. Continue Reading... Full story

Yahoo Finance • 14 days ago

Guardant Health Secures FDA Approval For Guardant360 CDx As Companion Diagnostic For HERNEXEOS

(RTTNews) - Guardant Health, Inc. (GH) announced that the U.S. FDA has approved Guardant360 CDx, a liquid biopsy test, as a companion diagnostic for Boehringer Ingelheim's HERNEXEOS (zongertinib tablets), the first targeted therapy for adu... Full story

Yahoo Finance • 16 days ago

HHS indicates skepticism on international cancer risk assessments

[US Department of Health and Human Services] HHS, along with the State Department, on Monday released a statement that indicated the federal government may challenge cancer hazard assessments issued by the International Agency for Researc... Full story

Yahoo Finance • 23 days ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and More

Quick Read: Stocks started the week where they left off Friday, with all the major indices except the Russell 2000 closing higher. The S&P 500, looking to post its 10th consecutive week of gains, once again closed at an all-time high on M... Full story

Yahoo Finance • 23 days ago

3 Reasons GH is Risky and 1 Stock to Buy Instead

Over the past six months, Guardant Health has been a great trade, beating the S&P 500 by 11.7%. Its stock price has climbed to $129.08, representing a healthy 22.7% increase. This was partly thanks to its solid quarterly results, and the r... Full story

Yahoo Finance • 29 days ago

Guardant Health Just Broke Out On Bullish News For Its Colon Cancer-Detecting Blood Test

Guardant Health stock spiked Wednesday after the American Cancer Society recommended its blood test as a screening tool for colon cancer. Continue Reading... Full story

Yahoo Finance • last month

Stock Market Today: Dow Wavers On Jobless Claims; Biotechs Ease, Nvidia Waffles On Earnings (Live Coverage)

Stock Market Today: The Dow Jones index dropped Thursday after surprise jobless claims data. Nvidia stock waffled on earnings. Continue Reading... Full story

Yahoo Finance • last month

Why Guardant Health (GH) Stock Is Down Today

What Happened? Shares of diagnostics company Guardant Health (NASDAQ:GH) fell 4.1% in the afternoon session after Co-CEO AmirAli Talasaz sold 50,000 shares of company stock, a transaction valued at over $5 million. Large stock sales by t... Full story

Yahoo Finance • 2 months ago

Does Guardant Health (GH) Have Long-Runway for Growth?

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. Baron Health Care Fund (the Fund) declined 6.97% (Institutional Sha... Full story

Yahoo Finance • 2 months ago

Pfizer, Arvinas breast cancer therapy approved by the FDA

[US Food and Drug Administration (FDA)] The U.S. Food and Drug Administration on Friday approved vepdegestrant, a breast cancer therapy developed by Pfizer (PFE [https://seekingalpha.com/symbol/PFE]) and Arvinas (ARVN [https://seekingalph... Full story

Yahoo Finance • 2 months ago

Q4 Earnings Roundup: Quest (NYSE:DGX) And The Rest Of The Testing & Diagnostics Services Segment

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Quest (NYSE:DGX) and the rest of the testing & diagnostics services s... Full story

Yahoo Finance • 3 months ago

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have outperformed the market lately as the 1.1% drawdown for healthcare stocks over the p... Full story

Yahoo Finance • 3 months ago

Guardant Health (GH) and Verana Health Announces New Partnership

Guardant Health, Inc. (NASDAQ:GH) is one of the best high growth healthcare stocks to buy now. Guardant Health, Inc. (NASDAQ:GH) and Verana Health announced on March 24 a new partnership aimed at allowing biopharmaceutical researchers to a... Full story

Yahoo Finance • 3 months ago

Why Guardant Health (GH) Stock Is Falling Today

What Happened? Shares of diagnostics company Guardant Health (NASDAQ:GH) fell 3% in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertain... Full story

Yahoo Finance • 3 months ago

3 Growth Stocks We Think Twice About

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajec... Full story

Yahoo Finance • 3 months ago

Guardant Health (GH) Partners With Manulife to Launch Shield Multi-Cancer Detection Test in Asia

Guardant Health Inc. (NASDAQ:GH) is one of the most promising stocks under $100 to buy. On March 16, Guardant Health announced the launch of its Shield multi-cancer detection/MCD test in several Asian markets through a first-of-its-kind pa... Full story

Yahoo Finance • 3 months ago

Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View

Guardant Health, Inc. (NASDAQ:GH) is one of the best growth stocks to buy according to billionaires. As of March 13, 2026, Guardant Health carried a Moderate Buy consensus from 23 analysts, based on 21 Buy ratings, one Hold, and one Sell.... Full story